PTH



PTH

S1SS1V2VV2S3SS3E4EE4I5II5Q6QQ6L7LL7M8MM8H9HH9N10NN10L11LL11G12GG12K13KK13H14HH14L15LL15N16NN16S17SS17M18MM18E19EE19R20RR20V21VV21E22EE22W23WW23L24LL24R25RR25K26KK26K27KK27L28LL28Q29QQ29D30DD30V31VV31H32HH32N33NN33F34FF34V35VV35A36AA36L37LL37G38GG38A39AA39P40PP40L41LL41A42AA42P43PP43R44RR44D45DD45A46AA46G47GG47... and 37 more residue(s)...... and 37 more residue(s)

SMILES None
InChIKey None
Sequence SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNFVALGAPLAPRDAGSQRPRKKEDNVLVESHEKSLGEADKADVNVLTKAKSQ

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations secretin

No bioactivity data available.

PTH

S1SS1V2VV2S3SS3E4EE4I5II5Q6QQ6L7LL7M8MM8H9HH9N10NN10L11LL11G12GG12K13KK13H14HH14L15LL15N16NN16S17SS17M18MM18E19EE19R20RR20V21VV21E22EE22W23WW23L24LL24R25RR25K26KK26K27KK27L28LL28Q29QQ29D30DD30V31VV31H32HH32N33NN33F34FF34V35VV35A36AA36L37LL37G38GG38A39AA39P40PP40L41LL41A42AA42P43PP43R44RR44D45DD45A46AA46G47GG47... and 37 more residue(s)...... and 37 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations secretin

Compound is not listed as a drug.